Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Approaches to Identify and Care for Individuals With Inherited Cancer Syndromes

NCT04494945 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT04494945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04494945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Approaches to Identify and Care for Individuals With Inherited Cancer Syndromes
Lead sponsor
OHSU Knight Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
March 9, 2020
Completion date
December 31, 2027
Enrollment
27,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brca1/2-associated hereditary breast and ovarian cancer syndrome, breast ductal carcinoma in situ, hematopoietic and lymphoid system neoplasm, hereditary neoplastic syndrome, lynch syndrome, malignant solid neoplasm